142 related articles for article (PubMed ID: 7654828)
1. Biology and treatment of nasopharyngeal cancer.
Fandi A; Cvitkovic E
Curr Opin Oncol; 1995 May; 7(3):255-63. PubMed ID: 7654828
[TBL] [Abstract][Full Text] [Related]
2. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects.
Altun M; Fandi A; Dupuis O; Cvitkovic E; Krajina Z; Eschwege F
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):859-77. PubMed ID: 7790274
[TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal carcinoma.
Brennan B
Orphanet J Rare Dis; 2006 Jun; 1():23. PubMed ID: 16800883
[TBL] [Abstract][Full Text] [Related]
4. Nasopharyngeal carcinoma: diagnosis, staging, and management.
Neel HB
Oncology (Williston Park); 1992 Feb; 6(2):87-95; discussion 99-102. PubMed ID: 1532503
[TBL] [Abstract][Full Text] [Related]
5. Childhood nasopharyngeal carcinoma: from biology to treatment.
Ayan I; Kaytan E; Ayan N
Lancet Oncol; 2003 Jan; 4(1):13-21. PubMed ID: 12517535
[TBL] [Abstract][Full Text] [Related]
6. Nasopharyngeal carcinoma.
Wei WI; Sham JS
Lancet; 2005 Jun 11-17; 365(9476):2041-54. PubMed ID: 15950718
[TBL] [Abstract][Full Text] [Related]
7. Optimal management of nasopharyngeal carcinoma.
Faivre S; Janot F; Armand JP
Curr Opin Oncol; 2004 May; 16(3):231-5. PubMed ID: 15069318
[TBL] [Abstract][Full Text] [Related]
8. [Cancers of the cavum].
Marandas P; Marandas N
Rev Prat; 2000 Sep; 50(14):1556-61. PubMed ID: 11068620
[TBL] [Abstract][Full Text] [Related]
9. Advances in nasopharyngeal carcinoma.
Guigay J
Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
[TBL] [Abstract][Full Text] [Related]
10. Undifferentiated carcinoma of nasopharyngeal type (UCNT): a Swiss single-institutional experience during 1990-2005.
Sidler D; Thum P; Winterhalder R; Huber G; Haerle SK
Swiss Med Wkly; 2010 May; 140(19-20):273-9. PubMed ID: 19950040
[TBL] [Abstract][Full Text] [Related]
11. What's new in the biology and treatment of undifferentiated carcinoma of nasopharyngeal type?
Carbone A; Dolcetti R; Shaha AR; Gloghini A; Molinari R; Rinaldo A; Boiocchi M; Wei WI; Ferlito A
Acta Otolaryngol; 2001 Dec; 121(8):884-95. PubMed ID: 11813890
[No Abstract] [Full Text] [Related]
12. Nasopharyngeal carcinoma. Biology, natural history, and therapeutic implications.
Cvitkovic E; Bachouchi M; Armand JP
Hematol Oncol Clin North Am; 1991 Aug; 5(4):821-38. PubMed ID: 1890068
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of nasopharyngeal tumors.
Oenbrink JD
South Med J; 1973 Feb; 66(2):209-12. PubMed ID: 4687592
[No Abstract] [Full Text] [Related]
14. Review of nasopharyngeal carcinoma.
Jeyakumar A; Brickman TM; Jeyakumar A; Doerr T
Ear Nose Throat J; 2006 Mar; 85(3):168-70, 172-3, 184. PubMed ID: 16615599
[TBL] [Abstract][Full Text] [Related]
15. [Undifferentiated carcinoma of the nasopharynx: epidemiological, clinical and therapeutic aspects].
Fandi A; Yanes B; Taamma A; Azli N; Armand JP; Dupuis O; Eschwège F; Schwaab G; Cvitkovic E
Bull Cancer; 1994 Jul; 81(7):571-86. PubMed ID: 7742599
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal carcinoma in children--a retrospective review and demonstration of Epstein-Barr viral genomes in tumor cell cytoplasm: a report of the Pediatric Oncology Group.
Hawkins EP; Krischer JP; Smith BE; Hawkins HK; Finegold MJ
Hum Pathol; 1990 Aug; 21(8):805-10. PubMed ID: 2167287
[TBL] [Abstract][Full Text] [Related]
17. Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.
Chan AT; Ma BB; Lo YM; Leung SF; Kwan WH; Hui EP; Mok TS; Kam M; Chan LS; Chiu SK; Yu KH; Cheung KY; Lai K; Lai M; Mo F; Yeo W; King A; Johnson PJ; Teo PM; Zee B
J Clin Oncol; 2004 Aug; 22(15):3053-60. PubMed ID: 15284255
[TBL] [Abstract][Full Text] [Related]
18. Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.
Azli N; Fandi A; Bachouchi M; Rahal M; Lianes P; Wibault P; Boussen H; Eschwege F; Armand JP; Cvitkovic E
Cancer J Sci Am; 1995; 1(3):222-9. PubMed ID: 9166480
[TBL] [Abstract][Full Text] [Related]
19. The significance of serologic test for EB-virus antibody in occult type nasopharyngeal carcinoma.
Furukawa M; Takimoto T; Morishita K; Komori T; Ishiguro H; Umeda R
Auris Nasus Larynx; 1983; 10(1):43-8. PubMed ID: 6311149
[TBL] [Abstract][Full Text] [Related]
20. Does induction chemotherapy have a role in the management of nasopharyngeal carcinoma? Results of treatment in the era of computerized tomography.
Garden AS; Lippman SM; Morrison WH; Glisson BS; Ang KK; Geara F; Hong WK; Peters LJ
Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1005-12. PubMed ID: 8985020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
